Rebecca Byam Hcw Biologics Inc. (HCWB) insider trading activity
Rebecca Byam is Chief Financial Officer of HCW Biologics Inc.. Currently has a direct ownership of 43,010 shares of HCWB, which is worth approximately $181,072. The most recent transaction as insider was on Aug 29, 2022, when has been sold 10,000 shares (Common Stock) at a price of $2.57 per share, resulting in proceeds of $25,700. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
43K
96.89%
3M change
96.89%
12M change
Total Value Held
$181,072
Rebecca Byam Transaction History
RB
Rebecca Byam
Chief Financial Officer
Miramar, FL